Yang Q, Li LY. Network pharmacological and molecular docking study of the effect of Liu-Wei-Bu-Qi capsule on lung cancer. World J Clin Cases 2023; 11(31): 7593-7609 [PMID: 38078145 DOI: 10.12998/wjcc.v11.i31.7593]
Corresponding Author of This Article
Qing Yang, MMed, Doctor, The Second Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, No. 117 Meishan Road, Hefei 230031, Anhui Province, China. cbdcnmyy929@sina.com
Research Domain of This Article
Oncology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 3 Analysis of topological parameters of key targets
Name
Closeness
Betweenness
Degree
TP53
0.839506
0.095155
56
EGFR
0.790698
0.051782
51
ALB
0.781609
0.077526
50
ESR1
0.747253
0.054759
47
HSP90AA1
0.764045
0.074274
47
SRC
0.73913
0.035499
45
HIF1A
0.731183
0.023561
44
MAPK3
0.723404
0.033332
43
TNF
0.708333
0.027768
41
MAPK1
0.660194
0.018393
34
PTGS2
0.660194
0.013252
34
SMAD3
0.635514
0.007272
30
AR
0.618182
0.005023
29
STAT1
0.623853
0.00514
29
MMP9
0.62963
0.006427
29
IGF1R
0.623853
0.00413
28
Table 4 Kyoto Encyclopedia of Genes and Genomes pathway enrichment information
Pathway
Count
P value
Estrogen signaling pathway
11
1.09E-08
Thyroid hormone signaling pathway
10
5.77E-08
VEGF signaling pathway
7
5.6E-07
Toll-like receptor signaling pathway
8
1.92E-06
Prolactin signaling pathway
7
2.44E-06
FoxO signaling pathway
8
1.27E-05
PI3K-Akt signaling pathway
13
3.76E-05
HIF-1 signaling pathway
7
4.45E-05
Sphingolipid signaling pathway
7
5.48E-05
Neurotrophin signaling pathway
7
5.77E-05
Table 5 Molecular docking for key targets and their related compounds
Targets
PDB ID
Compounds
Binding energy (kcal/mol)
TP53
4MZR
protocatechuic acid
-42.1348
ALB
4BKE
Dianthramine
-49.0138
ESR1
4ZNH
quercetin
-37.218
kaempferol
-37.1051
HSP90AA1
3WQ9
quercetin
-40.1408
kaempferol
-38.241
SRC
1Y57
quercetin
-37.7868
HIF1A
1L8C
quercetin
-38.3202
kaempferol
-49.377
MAPK3
2ZOQ
quercetin
-61.2015
TNF
2E7A
quercetin
-50.4514
MAPK1
1TVO
formononetin
-48.1226
Citation: Yang Q, Li LY. Network pharmacological and molecular docking study of the effect of Liu-Wei-Bu-Qi capsule on lung cancer. World J Clin Cases 2023; 11(31): 7593-7609